Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald's, Pfizer and More
Express Scripts Holding Co. (NASDAQ: ESRX) was down 3.2% at $79.31 on Tuesday after the Bezos, Buffett, Dimon health initiative. Its shares were indicated up 0.9% on Wednesday after RBC Capital Markets raised its rating to Outperform from Market Perform and gave a $98 price target.
FitBit Inc. (NYSE: FIT) was raised to Hold from Sell at Stifel, but the firm lowered its price target to $5.50 from $6.00 (versus a $5.20 close).
Foot Locker Inc. (NYSE: FL) was raised to Outperform from Perform with a $70 price target at Oppenheimer. Shares were indicated up over 3% at $51.50 on Wednesday morning.
ImmunoGen Inc. (NASDAQ: IMGN) was started with a Buy rating and assigned an $18 price target (versus an $8.32 close) at H.C. Wainwright. ImmunoGen was indicated up 5% at $8.76 on Wednesday morning, and its 52-week range is $2.28 to $8.84.
Jacobs Engineering Corp. (NYSE: JEC) was raised to Neutral from Sell with a $75 price target (versus a $69.70 close) at Goldman Sachs.
McDonald’s Corp. (NYSE: MCD) was maintained as Hold at Independent Research but the target price was raised to $185 from $175. BMO Capital Markets reiterated its Outperform rating and raised its target to $190 from $175.
MetLife Inc. (NYSE: MET) was maintained as Buy but was removed from the Conviction Buy List at Goldman Sachs. The price target of $57 compares with a $49.73 prior close.
Natural Grocers by Vitamin Cottage Inc. (NYSE: NGVC) was raised to Outperform from Sector Perform with an $11 price target (versus an $8.19 close) at RBC Capital Markets.
Nike Inc. (NYSE: NKE) was reiterated as Buy and the price target was raised to $78 from $74 (versus a $67.33 close) at Citigroup.
Pfizer Inc. (NYSE: PFE) was down 3.13% at $37.80 on Tuesday after earnings and after the Bezos, Buffett, Dimon health initiative. Credit Suisse reiterated its Neutral rating and raised its target price to $39 from $37. Independent Research raised its target to $40 from $39 with its Hold rating. BMO Capital Markets raised Pfizer’s target price to $43 from $39, and Leerink raised its target to $38 from $35.
SAP SE (NYSE: SAP) was reiterated as Buy with a $130 price target (versus a $110.81 close) at Argus.
TCF Financial Corp. (NYSE: TCB) was downgraded to Underweight from Neutral with a $22 price target (versus a $21.59 close) at JPMorgan.
Trimble Inc. (NASDAQ: TRMB) was reiterated as Outperform and the price target was raised to $50 from $45 (versus a $44.17 close) at Oppenheimer.
United Continental Holdings Inc. (NYSE: UAL) was raised to Outperform from Market Perform with an $81 price target (versus a $67.02 close) at Bernstein.
U.S. Bancorp (NYSE: USB) was downgraded to Underweight from Neutral with a $58 price target (versus a $57.40 close) at JPMorgan.
Zimmer Biomet Holdings Inc. (NYSE: ZBH) was raised to Buy from Hold with a $168 price target (versus a $125.94 close) at Stifel.
Tuesday’s top analyst upgrades and downgrades were in Abbott Labs, Alphabet, Amazon.com, General Electric, Gilead Sciences, Intel, Seagate Technology, U.S. Steel and many more.